Concepedia

A. Oaknin

AO

2

Publications

68

Citations

2

H-Index

2022

Active since

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Agostino Gemelli University Polyclinic

Princess Margaret Cancer Centre

Guy's and St Thomas' NHS Foundation Trust

A. Oaknin is an author at Vall d'Hebron Hospital Universitari specializing in ovarian cancer, cancer therapeutics, and oncology.

Top concepts

Publications per year

2022–2024

2

Publications

2

518O Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mutation

A.M. Oza, A.S. Lisyanskaya, A.A. Fedenko et al. · Annals of Oncology · 2022 · 39 citations

, , +9

LBA30 ATHENA-COMBO, a phase III, randomized trial comparing rucaparib (RUCA) + nivolumab (NIVO) combination therapy vs RUCA monotherapy as maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC)

B.J. Monk, A. Oaknin, David M. O’Malley et al. · Annals of Oncology · 2024 · 29 citations

, , +8

Rows per page

1–2 of 2